Trial intelligence / Profile preview

Randomized double-blind trial of intra-articular platelet-rich plasma versus betamethasone + bupivacaine for knee osteoarthritis

2010-023977-21Phase 3Completed

Sponsor
Nayana Joshi Jubert
Start
Feb 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Platelet-rich plasma with Betamethasone + bupivacaine (2 arms). Primary endpoint: Visual analog scale pain score. Started Feb 2011; status: completed.

02

Drugs

platelet-rich plasmabetamethasonebupivacaine
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2010-023977-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023977-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call